Sonnet Biotherapeutics Stock Forecast - Naive Prediction
| SONNDelisted Stock | USD 1.26 1.90 60.13% |
The Naive Prediction forecasted value of Sonnet Biotherapeutics Holdings on the next trading day is expected to be 0.89 with a mean absolute deviation of 0.48 and the sum of the absolute errors of 29.09. Sonnet Stock Forecast is based on your current time horizon.
As of today the value of rsi of Sonnet Biotherapeutics' share price is below 20 . This usually implies that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Sonnet Biotherapeutics hype-based prediction, you can estimate the value of Sonnet Biotherapeutics Holdings from the perspective of Sonnet Biotherapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Sonnet Biotherapeutics Holdings on the next trading day is expected to be 0.89 with a mean absolute deviation of 0.48 and the sum of the absolute errors of 29.09. Sonnet Biotherapeutics after-hype prediction price | USD 0.81 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sonnet |
Sonnet Biotherapeutics Additional Predictive Modules
Most predictive techniques to examine Sonnet price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Sonnet using various technical indicators. When you analyze Sonnet charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Sonnet Biotherapeutics Naive Prediction Price Forecast For the 12th of January 2026
Given 90 days horizon, the Naive Prediction forecasted value of Sonnet Biotherapeutics Holdings on the next trading day is expected to be 0.89 with a mean absolute deviation of 0.48, mean absolute percentage error of 0.35, and the sum of the absolute errors of 29.09.Please note that although there have been many attempts to predict Sonnet Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Sonnet Biotherapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Sonnet Biotherapeutics Stock Forecast Pattern
| Backtest Sonnet Biotherapeutics | Sonnet Biotherapeutics Price Prediction | Buy or Sell Advice |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Sonnet Biotherapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Sonnet Biotherapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 117.0702 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.4768 |
| MAPE | Mean absolute percentage error | 0.1122 |
| SAE | Sum of the absolute errors | 29.0852 |
Predictive Modules for Sonnet Biotherapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Sonnet Biotherapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sonnet Biotherapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sonnet Biotherapeutics stock to make a market-neutral strategy. Peer analysis of Sonnet Biotherapeutics could also be used in its relative valuation, which is a method of valuing Sonnet Biotherapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Sonnet Biotherapeutics Market Strength Events
Market strength indicators help investors to evaluate how Sonnet Biotherapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sonnet Biotherapeutics shares will generate the highest return on investment. By undertsting and applying Sonnet Biotherapeutics stock market strength indicators, traders can identify Sonnet Biotherapeutics Holdings entry and exit signals to maximize returns.
Sonnet Biotherapeutics Risk Indicators
The analysis of Sonnet Biotherapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Sonnet Biotherapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting sonnet stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 10.16 | |||
| Standard Deviation | 14.75 | |||
| Variance | 217.59 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Sonnet Biotherapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sonnet Biotherapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonnet Biotherapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Sonnet Stock
The ability to find closely correlated positions to Sonnet Biotherapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sonnet Biotherapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sonnet Biotherapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sonnet Biotherapeutics Holdings to buy it.
The correlation of Sonnet Biotherapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sonnet Biotherapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sonnet Biotherapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sonnet Biotherapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in Sonnet Stock
If you are still planning to invest in Sonnet Biotherapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sonnet Biotherapeutics' history and understand the potential risks before investing.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |